Intervention: Casirivimab and Imdevimab Drug Combination
Found 23 matching trials
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19
PHASE3
Phase 1
* To evaluate the safety and tolerability of REGN10933+REGN10987 c...
COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19
PHASE1
The primary objectives of the study are:
* To characterize the concentrati...
COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease
PHASE1
Primary Objectives Phase 1 (Safety and Tolerability)
⢠Evaluate the safety...
COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers
PHASE2
The primary objectives of the study are:
* To evaluate the extent of effec...